Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
Seeking New Users for iSeq
The Changing Sequencing Landscape
For full access to this article login to GEN Select now.
Integral Molecular Sizes Up Ebola
Membrane Protein Specialist Maps Ebola’s Binding Sites to Advance Vaccine Discovery
- Ebola is the latest in a series of pathogenic viruses investigated by Integral Molecular, a research-oriented biotechnology company that has a sharp eye for viral membrane proteins. Before Integral Molecular turned its watchful gaze toward Ebola, the company kept tabs on chikungunya, hepatitis C, respiratory syncytial virus, and HIV. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.